全球糖尿病视网膜病变市场规模、份额、增长分析，按类型（增殖性糖尿病视网膜病变和非增殖性糖尿病视网膜病变），按管理（抗 VEGF、眼内类固醇注射） - 行业预测 2024-2031

Global Diabetic Retinopathy Market Size, Share, Growth Analysis, By Type(Proliferative Diabetic Retinopathy, and Non-proliferative diabetic retinopathy), By Management(Anti-VEGF, Intraocular Steroid Injection) - Industry Forecast 2024-2031

出版日期: 2024年03月23日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年，全球糖尿病视网膜病变市场规模为83.0亿美元，预计将从2023年的88.3亿美元增长到2031年的145.1亿美元，在预测期内（2024-2031年）复合年增长率为6.4%。

市场扩张预计将受到多种因素的推动，包括糖尿病发病率上升、人口老化以及与糖尿病相关的失明率上升。此外，人们对糖尿病认识的提高和新产品的推出也促进了市场的成长。糖尿病是一种普遍存在的全球性疾病，其特征是胰臟无法产生胰岛素，导致血糖水平升高并损害视网膜毛细血管，从而导致糖尿病性视网膜病变。高血糖水平和监测不足被认为是视网膜变性的危险因素，但早期发现糖尿病、适当用药、使用现代工具持续自我监测以及采用健康的生活方式可以减轻视网膜损伤并降低糖尿病视网膜病变的发病率。儘管采取了预防措施，糖尿病视网膜病变仍可能导致不可逆转的失明，因此需要早期检测策略，例如 Check Eye 提供的策略，这是一家利用人工智慧筛检糖尿病视网膜病变的健康科技公司。在英国，糖尿病视网膜病变是导致失明的主要原因之一，凸显了消费者意识和增加医疗保健支出的重要性。此外，预计到 2050 年，全球老龄化人口将增加两倍，维持健康的生活方式和定期监测血糖对于降低糖尿病及其併发症的风险至关重要。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 欧洲其他地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 拉丁美洲其他地区
中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- MEA 的其余部分

竞争格局

前 5 名玩家比较
2021 年关键参与者的市场定位
主要市场参与者所采取的策略
最佳制胜策略
近期市集活动
主要公司市占率（%），2021年

主要公司简介

Novartis AG
Roche Holding AG
Bayer AG
Regeneron Pharmaceuticals, Inc.
Allergan plc (AbbVie Inc.)
Carl Zeiss Meditec AG
Topcon Corporation
Nidek Co., Ltd.
Optos plc (Nikon Corporation)
Bausch Health Companies Inc.
Alcon Inc.
Santen Pharmaceutical Co., Ltd.
Lumenis Ltd. (XIO Group)
Iridex Corporation
Leica Microsystems (Danaher Corporation)
StemCells Inc. (Microbot Medical Inc.)
Bioptigen, Inc. (Metabolic Technologies Inc.)
CenterVue SpA
Visunex Medical Systems, Inc.
Clarity Medical Systems, Inc.

简介目录

Product Code: SQMIG35A2516

Global Diabetic Retinopathy Market size was valued at USD 8.30 billion in 2022 and is poised to grow from USD 8.83 billion in 2023 to USD 14.51 billion by 2031, growing at a CAGR of 6.4% during the forecast period (2024-2031).

The market expansion is expected to be propelled by several factors including the increasing incidence of diabetes, a growing aging population, and the rise in diabetes-related blindness. Additionally, heightened awareness of diabetes and the introduction of new products are contributing to market growth. Diabetes, a prevalent global condition characterized by the pancreas' inability to produce insulin, leads to elevated blood sugar levels and damage to retinal blood capillaries, resulting in diabetic retinopathy. High blood sugar levels and inadequate monitoring are considered risk factors for retinal degeneration, but early detection of diabetes, proper medication, continuous self-monitoring using modern tools, and embracing a healthy lifestyle can mitigate retinal damage and lower the incidence of diabetic retinopathy. Despite preventive efforts, diabetic retinopathy can lead to irreversible blindness, necessitating early detection strategies like those offered by Check Eye, a healthtech company leveraging AI to screen for diabetic retinopathy. In the UK, diabetic retinopathy ranks among the leading causes of blindness, underscoring the importance of consumer awareness and increased healthcare spending. Moreover, with the global aging population projected to triple by 2050, maintaining a healthy lifestyle and regular blood glucose monitoring are imperative to mitigate the risks associated with diabetes and its complications.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Diabetic Retinopathy Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Diabetic Retinopathy Market Segmental Analysis

The global diabetic retinopathy market is segmented based on type, management, and region. Based on type, the market is segmented into proliferative diabetic retinopathy, and non-proliferative diabetic retinopathy. With respect to categorization by management, the market is segmented into anti-VEGF, intraocular steroid injection, laser surgery, vitrectomy. Regionwise, the market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.

Drivers of the Global Diabetic Retinopathy Market

The diabetic retinopathy market is witnessing significant expansion, propelled by augmented investments in healthcare infrastructure, which foster improved healthcare provision and accessibility. Concurrently, concerted endeavors by public and private entities to boost awareness regarding diabetic retinopathy are bolstering market growth. Furthermore, favorable reimbursement conditions and a populace with substantial disposable income are fostering the market's expansion. The demographic shift towards an aging population, coupled with evolving lifestyles, further accelerates the market's growth trajectory.

Restraints in the Global Diabetic Retinopathy Market

The increasing occurrence of diabetic retinopathy is accompanied by insufficient awareness regarding the condition and the necessity of regular eye check-ups among individuals with diabetes. Restricted availability of eye care services, especially in remote or underserved regions, poses obstacles to early detection and prompt intervention.

Market Trends of the Global Diabetic Retinopathy Market

Increasingly acknowledged is the pivotal role of early detection and intervention in addressing diabetic retinopathy, with emphasis shifting towards implementing routine screening initiatives, raising awareness through campaigns, and adopting cutting-edge imaging techniques to facilitate prompt diagnosis, thereby enabling timely therapeutic interventions and more effective disease management.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Diabetic Retinopathy Market by Type

Market Overview
Proliferative Diabetic Retinopathy
and Non-proliferative diabetic retinopathy

Global Diabetic Retinopathy Market by Management

Market Overview
Anti-VEGF
Intraocular Steroid Injection
Laser Surgery
and Vitrectomy

Global Diabetic Retinopathy Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Novartis AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Holding AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bayer AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Regeneron Pharmaceuticals, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Allergan plc (AbbVie Inc.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Carl Zeiss Meditec AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Topcon Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nidek Co., Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Optos plc (Nikon Corporation)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bausch Health Companies Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alcon Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Santen Pharmaceutical Co., Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lumenis Ltd. (XIO Group)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Iridex Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Leica Microsystems (Danaher Corporation)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
StemCells Inc. (Microbot Medical Inc.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bioptigen, Inc. (Metabolic Technologies Inc.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CenterVue SpA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Visunex Medical Systems, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Clarity Medical Systems, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments